Eliquis 2.5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FAWF8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,966
Award facts
- Contract value 100% obligated
- $12,966.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,966.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). The contract, issued on May 12, 2025, with an ultimate completion date of May 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency and other government healthcare systems through competitively awarded contracts demonstrating capability across multiple therapeutic domains. The Eliquis supply under this delivery order supports military healthcare requirements for this anticoagulant medication. The DLA Troop Support Medical contract represents a flexible procurement vehicle that streamlines pharmaceutical acquisition for defense and veteran healthcare programs, with the agency planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards to ensure robust supply chain resilience across the federal medical supply network.
Quick answers
Who was awarded contract SPE2DB25FAWF8?
SPE2DB25FAWF8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FAWF8 worth?
The government has obligated $12,966 on SPE2DB25FAWF8.
Is contract SPE2DB25FAWF8 an order under another contract?
Yes. SPE2DB25FAWF8 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAWF8 competed?
The extent of competition for SPE2DB25FAWF8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award